Reversal of cyclophosphamide induced neutropenia by hypertransfusion and androgen therapy.
We injected 300 mg/kg Cyclophosphamide i.p. into female AKR mice and rendered them reversably neutropenic. Group A was hypertransfused; Group B received 5 mg Nandrolone decanoate i.m. q.d X 2; and Group C received both. Group D served as a control. White blood cell counts were followed every other day for 10 days. The nadirs seen on all groups appeared on day 5. At day 10 counts in Groups A, B, and D had returned to normal, while the pattern of granulocyte decline and recovery in Group C was significantly faster than that seen in other groups, returning to normal at day 8. Hypertransfusion and androgen administration together significantly ameliorated drug-induced leukopenia, suggesting synergism. Thus manipulation of the stem-cell compartment may be clinically feasible.
D000380:Agranulocytosis / Q000139:chemically induced*; D000818:Animals; D001803:Blood Transfusion; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D003520:Cyclophosphamide; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects; D007958:Leukocyte Count; D051379:Mice; D008806:Mice, Inbred AKR; D009277:Nandrolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077603:Nandrolone Decanoate; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy / Q000628:therapy
D009277:Nandrolone; D003520:Cyclophosphamide; D000077603:Nandrolone Decanoate